{"id":"https://genegraph.clinicalgenome.org/r/ff4973c1-4c88-4247-84ca-98f71428189fv1.0","type":"EvidenceStrengthAssertion","dc:description":"Biallelic germline variants in LCP2 (SLP76) were first reported in relation to combined T and B cell immunodeficiency in 2020 (PMID: 33231617). Patients with *LCP2*-related combined immunodeficiency demonstrate recurrent fungal infections with T cell dysfunction and associations with EBV-related infection and lymphoproliferation, platelet dysfunction and neutrophil dysfunction. Four variants were identified in the literature and are composed of missense, splice site and frameshift mutations (PMID: 33231617,36474126, 37211057). Evidence supporting this gene-disease relationship includes case-level and experimental data. Heterozygous carriers have not been reported to have a clinical phenotype. \n\n*LCP2* encodes for the protein SLP76, an important intermediate of T cell receptor signaling. Following T cell activation, SLP76 is recruited to membrane bound phosphorylated LAT by Gads and mediates the phosphorylation of ITK, resulting in the phosphorylation and PLC-gamma1. Activation of PLC-gamma1 is required for the initiation of the NFAT and MAPK signaling pathways, both of which are required for the generation of functional T cell signaling. A combination of cell lines and animal models have helped to identify the role SLP76 plays in the immune system. Studies in cell lines have identified interacting partners of SLP76, as well as important domains of the protein required for supporting T cell receptor signaling (PMID:7706237, 17420479, 10556826, 9665884, 16354835, 9257823). Mouse models of total SLP76 deficiency replicate peripheral T cell deficiency and platelet defect identified in patients (PMID: 9695951, 9884330). In these models, SLP76 deficient cells demonstrate a developmental block during double negative thymocyte development, leading to an absence of peripheral T cells (PMID: 9695951). Mouse models studying the impact of individual domains of SLP76 have shown different severity of thymocyte development block and resulting peripheral T cell survival, suggesting genotype-phenotype correlations (PMID: 11792851). This may be evident in the identified patients, as the age and presenting symptoms of the patients are varied.\n\nIn summary, there is definitive evidence to support this gene-disease relationship. This association has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.\n\nThis classification was approved by the ClinGen SCID-CID Working Group on 2/15/2024 (SOP Version 9).\n\n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ff4973c1-4c88-4247-84ca-98f71428189f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2024-06-04T16:52:48.598Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2024-02-15T18:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4eecddc-2f89-4bb4-b9e7-561d018850cb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2894c005-3928-4cbd-a3b5-2c63643b0ddc","type":"Finding","dc:description":"These models show similar T cell defects to what is seen in humans, but importantly show that mutations in different domains of the protein impact the development and function of T cell differently.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11792851","rdfs:label":"SLP76 transgenic mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0c5ae657-8535-479b-8519-799f7f6bdfd9","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df5855fd-d7b0-4dd6-bd16-9bcdf1cc0755","type":"Finding","dc:description":"Patients demonstrate reduction in thymic T cell output with a result of a narrowed T cell repertoire and T cell lymphopenia in some patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9695951","rdfs:label":"SLP76 deficient mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3cf35109-db4f-4d5b-9e38-e89f7b82e0a0","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de2c1cb9-c3da-4b82-8b98-73bb45e5516e","type":"Finding","dc:description":"restore TCR signaling readouts used in the paper.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9665884","rdfs:label":"spl76 deficient cell line","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43fd3178-c007-4b01-a0cf-c1edf38bc8b1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61b8e408-189b-4ae2-9146-101c197922a7","type":"FunctionalAlteration","dc:description":"reduced MAPK signaling, CD69 upregulation and Ca flux following TCR stimulation ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36474126","rdfs:label":"J14 reconstitution"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bb6ae66-d657-4f2b-a4ba-7a4637c90ed6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aafcbdb2-1298-463b-a2f7-6720d011e8bb","type":"Finding","dc:description":"Platelets from a patient with biallelic LCP2 variants also showed defects in collagen induced platelet aggregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9884330","rdfs:label":"Collagen induced platelet activation","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c9397d65-29db-4a7a-af46-df513b084879","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/716801c6-8004-407c-83bc-e30eb3a8fdbd","type":"Finding","dc:description":"The presence of SLP-76 is required for ITK of phosphorylate tyrosines required for recruitment of PLC-g1 and sustain TCR signaling. ITK has been associated with EBV-driven lymphomas, which has been seen in a patient with SLP-76 LOF variants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17420479","rdfs:label":"SLP-76:ITK","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/669bcbd2-195b-46ce-b496-6e5c99837e36","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/becf0dae-b830-4a71-8602-58bcdbc8abbc","type":"Finding","dc:description":"SLP76 labeled cDNA was hybridized to mRNA purified from human tissues.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7706237","rdfs:label":"Expression studies","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/3f14a481-2d4c-4cd0-a930-03db5bff6b9b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e38ab9d-efc9-46a7-8ff9-4364330c39f5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b37d686-ce33-4702-a776-27d409f093b2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b37d686-ce33-4702-a776-27d409f093b2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transduction of variant shows reduced phosphorylation of downstream targets following activation.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6b37d686-ce33-4702-a776-27d409f093b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37211057","allele":{"id":"https://genegraph.clinicalgenome.org/r/43bd193e-51fa-4f93-a1f6-70f98577648a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005565.5(LCP2):c.569C>G (p.Pro190Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3555676"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1d88e089-c05b-4123-a5fd-97af7497c52e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d88e089-c05b-4123-a5fd-97af7497c52e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transduction of variant shows reduced phosphorylation of downstream targets following activation.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1d88e089-c05b-4123-a5fd-97af7497c52e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37211057","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e74c069-5c72-416b-8fe2-09b2449c6331","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005565.5(LCP2):c.610C>T (p.Arg204Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA132028167"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7e38ab9d-efc9-46a7-8ff9-4364330c39f5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37211057","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":26,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5e74c069-5c72-416b-8fe2-09b2449c6331"},{"id":"https://genegraph.clinicalgenome.org/r/43bd193e-51fa-4f93-a1f6-70f98577648a"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0030253","obo:HP_0032140","obo:HP_0002037","obo:HP_0031368","obo:HP_0500265","obo:HP_0001974","obo:HP_0001890","obo:HP_0002720","obo:HP_0001894"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/6b37d686-ce33-4702-a776-27d409f093b2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1d88e089-c05b-4123-a5fd-97af7497c52e_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c5b38952-71fd-4635-8dc4-23c17a48a826_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb3657f4-f3cd-4018-b89b-3af141772fb9","type":"EvidenceLine","dc:description":"Parental consanguinity ","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb3657f4-f3cd-4018-b89b-3af141772fb9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced phosphorylation of downstream singling molecules, reduced T cell signaling in response to TCR ligation, absence of SLP76 expression, no correction of SLP76 deficient cell line activation when transducer with variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bb3657f4-f3cd-4018-b89b-3af141772fb9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33231617","allele":{"id":"https://genegraph.clinicalgenome.org/r/95820c9a-89ce-43a4-a348-ee333736bc73","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005565.5(LCP2):c.957+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362114045"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/c5b38952-71fd-4635-8dc4-23c17a48a826","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33231617","rdfs:label":"Pt1","ageType":"AgeAtReport","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/95820c9a-89ce-43a4-a348-ee333736bc73"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002098","obo:HP_0030253","obo:HP_0000988","obo:HP_0030049","obo:HP_0032218","obo:HP_0001508","obo:HP_0031545","obo:HP_0031292","obo:HP_0032247","obo:HP_0000967","obo:HP_0001903","obo:HP_0008320","obo:HP_0031393"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bb3657f4-f3cd-4018-b89b-3af141772fb9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a620950c-da9f-45e9-a273-4fe3648d7756_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/151a5744-3ddf-4081-b40e-a053818d9b43","type":"EvidenceLine","dc:description":"Parental consanguinity ","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/151a5744-3ddf-4081-b40e-a053818d9b43_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot, TCR signaling, Ca signaling all reduced ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/151a5744-3ddf-4081-b40e-a053818d9b43_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36474126","allele":{"id":"https://genegraph.clinicalgenome.org/r/54cf76f0-2707-43b2-adc9-25ae458fdd19","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005565.5(LCP2):c.991del (p.Gln331SerfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695205679"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a620950c-da9f-45e9-a273-4fe3648d7756","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36474126","rdfs:label":"Patient 1_1","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/54cf76f0-2707-43b2-adc9-25ae458fdd19"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001287","obo:HP_0001873","obo:HP_0002014","obo:HP_0020072","obo:HP_0001876","obo:HP_0030049","obo:HP_0031545","obo:HP_0020102","obo:HP_0030253","obo:HP_0001433","obo:HP_0002716","obo:HP_0040218","obo:HP_0011839"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/151a5744-3ddf-4081-b40e-a053818d9b43_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7}],"evidenceStrength":"Definitive","sequence":8345,"specifiedBy":"GeneValidityCriteria10","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/D_IvfuK7DKM","type":"GeneValidityProposition","disease":"obo:MONDO_0030302","gene":"hgnc:6529","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3f14a481-2d4c-4cd0-a930-03db5bff6b9b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}